[1]
Jagielska , B., Czubek, A., Talasiewicz , K., Twarowski , A., Rutkowski , P., Krzakowski , M., Saetre , B. and Malecki , M. 2023. Assessment of efficacy of trastuzumab (Herceptin) comprising adjuvant therapy of HER2+ breast cancer patients determined based upon statistical analysis of overall survival (OS) and disease-free survival (PFS) . Molecular Cellular Therapy and Mechanism. 6, 1 (Mar. 2023), 37–49.